Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome Meeting Abstract
| Authors: | Manshouri, T.; Estrov, Z.; Knez, L.; Zhang, Y.; Levine, R. L.; Kantarjian, H. M.; Verstovsek, S. |
| Abstract Title: | Ruxolitinib, a janus kinase (JAK)-1 and-2 inhibitor modulates microrna (miR) levels in patients with myelofibrosis (MF): miR levels might predict MF treatment outcome |
| Meeting Title: | 53rd Annual Meeting and Exposition of the American Society of Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis |
| Journal Title: | Blood |
| Volume: | 118 |
| Issue: | 21 |
| Meeting Dates: | 2011 Dec 10-13 |
| Meeting Location: | San Diego, CA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2011-11-01 |
| Start Page: | 761 |
| Language: | English |
| ACCESSION: | WOS:000299597102339 |
| PROVIDER: | wos |
| DOI: | 10.1182/blood.V118.21.1744.1744 |
| Notes: | --- - Meeting Abstract: 1744 - 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis - DEC 10-13, 2011 - San Diego, CA - "Source: Wos" |
